Minerva Neurosciences NERV
NASDAQ NERV
$2.46 -0.17 (-6.46%)
As of: Nov 10, 2026 · 3:10 PM EST

Minerva Neurosciences (NERV) EV to EBIT (2020 - 2021)

Updated

Minerva Neurosciences' EV to EBIT came in at 6.75 for Q1 2021, down 83.3% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) EV to EBIT (2020 - 2021) Analysis & Trends

Over the trailing twelve months to Mar 31, 2021, Minerva Neurosciences reported EV to EBIT of -7.34; for FY2020, it came in at 40.40.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Minerva Neurosciences 121.62 Mn -126.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 6.75
Dec 31, 2020 40.39
API Access

Minerva Neurosciences EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=NERV&period=max&api_key=YOUR_API_KEY